Cytokines in pericardial effusion of patients with inflammatory pericardial disease

Konstantinos Karatolios1, Rainer Moosdorf, Bernhard Maisch

  • 1Department of Cardiology, University Hospital Giessen & Marburg, 35043 Marburg, Germany. karatoli@med.uni-marburg.de

Insights

Vascular Endothelial Growth Factor (VEGF) and basic Fibroblast Growth Factor (bFGF) are elevated in inflammatory pericardial effusion, suggesting their involvement in the disease's development. These angiogenic cytokines play a key role in inflammatory heart conditions.

Area of Science:

  • Cardiology
  • Biochemistry
  • Immunology

Background:

  • The specific roles of inflammatory and angiogenic cytokines in inflammatory pericardial effusion (PE) are not fully understood.
  • Investigating these cytokines is crucial for understanding the pathogenesis of inflammatory heart conditions.

Purpose of the Study:

  • To assess and compare the levels of vascular Endothelial Growth Factor (VEGF), basic Fibroblast Growth Factor (bFGF), Interleukin-1 beta (IL-1β), and Tumor Necrosis Factor-alpha (TNF-α) in pericardial effusion and serum.
  • To determine the relationship between these cytokines and the causes of inflammatory PE (autoreactive vs. viral) and coronary artery disease (CAD).

Main Methods:

  • Enzyme-linked immunosorbent assay (ELISA) was used to measure cytokine levels.
  • Samples were collected from patients with inflammatory PE (autoreactive and viral) and control patients with CAD.
  • Cytokine levels in pericardial fluid (PF) and serum were analyzed.

Main Results:

  • VEGF levels were significantly higher in both PE and serum of patients with inflammatory PE compared to CAD patients.
  • Pericardial bFGF levels were higher than serum levels in both inflammatory PE and CAD groups.
  • Pericardial VEGF correlated positively with inflammation markers, while bFGF showed a negative correlation. IL-1β and TNF-α were rarely detected.

Conclusions:

  • Elevated levels of VEGF and bFGF in pericardial effusion indicate their potential involvement in the pathogenesis of inflammatory pericardial disease.
  • These findings highlight the importance of angiogenic cytokines in inflammatory cardiovascular conditions.
Abstract

Related Concept Videos

Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...